ROSEVILLE, Calif.--Dutton Associates continues coverage of Patriot Scientific (OTCBB: PTSC), raising its rating to Strong Speculative Buy and a price target at $.55. The 15-page report by Dutton senior analyst Richard W. West, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks, Reuters, Knobias, and other leading financial portals.

Since our February 7, 2008 Update Research Report, Patriot Scientific announced changes in management. After the resignation of James Turley, Rick Goerner was appointed as Interim Chief Executive Officer and Interim President. From 2002 through 2006, Goerner served as President and Chief Executive Officer of Transdimension Inc., an Irvine, California-based, venture-financed, technology company providing embedded universal serial bus (USB) silicon and software solutions. In addition, Donald Schrock, formerly of Qualcomm CDMA Technologies Group until his retirement in 2003, was appointed to Patriot Scientific’s Board of Directors. This management team is aggressively pursuing an acquisition program to bring in an operating company to Patriot Scientific. Since January 2006 through February 29, 2008, TPL Group has granted 44 licenses resulting in recognized revenue of $219.7 million to Phoenix Digital Solutions. Patriot Scientific’s share in that revenue since January 2006 was $92.8 million. Since January 2008, the pace of patent license sales has accelerated and, more importantly, the recent sales were to major well known, recognizable names. Taking advantage of attractive price-point opportunities, Patriot Scientific announced a resumption of the Company’s open market share repurchase program. Patriot Scientific is debt-free, with a strong cash-heavy balance sheet. We feel comfortable with this new management team and look forward to the execution of the aggressive merger and acquisition strategy.

About Dutton Associates

Dutton Associates is one of the largest independent investment research firms in the U.S. Its 30 senior analysts are primarily CFAs, and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 140 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.

The cost of enrollment in our one-year continuing research program is US $35,000 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $35,000 from the Company for 4 Research Reports with coverage commencing on 11/27/2006. The Firm does not accept any equity compensation. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.

Dutton Associates
John Dutton, 916/960-0623